Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Respir Med. 2022 Sep;201:106933. doi: 10.1016/j.rmed.2022.106933. Epub 2022 Jul 16.
Idiopathic pulmonary fibrosis (IPF) is diagnosed incidentally in some patients with minimal or no respiratory symptoms. The clinical features of such patients are unknown. Herein we aimed to clarify the prevalence, clinical course, and prognostic factors of patients who were incidentally diagnosed with IPF.
The files of consecutive patients with newly diagnosed IPF were retrospectively reviewed to determine the methods involved in their diagnosis, and their outcomes.
Among a total of 107 patients with newly diagnosed IPF, 35 (32.7%) were diagnosed incidentally, including 18 undergoing annual health check-ups and 17 undergoing assessment for other medical problems. The median survival from the time of diagnosis was 4.9 years for the 35 patients diagnosed incidentally, which was comparable to the median survival of 3.9 years for the 72 who were not diagnosed incidentally. The body mass index (BMI) was the sole independent predictor of survival (hazard ratio 0.78, 95% confidence interval 0.65-0.93, p = 0.006) in patients diagnosed incidentally.
Nearly one third of patients with IPF were diagnosed incidentally, and their survival was still poor. Identifying patients during the earliest stage of IPF, particularly those with a low BMI, is warranted.
特发性肺纤维化(IPF)在一些呼吸症状轻微或无的患者中偶发诊断。这些患者的临床特征尚不清楚。在此,我们旨在阐明偶发诊断为 IPF 的患者的患病率、临床病程和预后因素。
回顾性分析连续确诊的 IPF 患者的病历,以确定其诊断方法和结局。
在总共 107 例新诊断的 IPF 患者中,35 例(32.7%)为偶发性诊断,其中 18 例接受年度健康检查,17 例因其他医疗问题接受评估。35 例偶发性诊断患者从诊断到死亡的中位生存时间为 4.9 年,与未偶发性诊断的 72 例患者的中位生存时间 3.9 年相当。在偶发性诊断患者中,体重指数(BMI)是唯一独立的生存预测因素(风险比 0.78,95%置信区间 0.65-0.93,p=0.006)。
近三分之一的 IPF 患者为偶发性诊断,其生存仍然较差。有必要在 IPF 的最早阶段识别患者,特别是 BMI 较低的患者。